These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8278331)

  • 1. [Congenital dyserythropoiesis. Value of isotopic exploration with iron 59 and chromium 51 marked red cells].
    Vuillez JP; Molina L; Bachelot C; Bost M; Hollard D
    Presse Med; 1993 Oct; 22(33):1709. PubMed ID: 8278331
    [No Abstract]   [Full Text] [Related]  

  • 2. Excess of Pappenheimer bodies (siderocytes) in two splenectomized siblings with congenital dyserythropoietic anemia--type II (CDA-II) and iron overload.
    Chrobák L; Matysová J
    Acta Medica (Hradec Kralove); 2004; 47(3):187-8. PubMed ID: 15568737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type IV congenital dyserythropoietic anemia with an unusual response to splenectomy.
    Bird AR; Karabus CD; Hartley PS
    Am J Pediatr Hematol Oncol; 1985; 7(2):196-9. PubMed ID: 3842565
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating nucleated red blood cells following splenectomy in a patient with congenital dyserythropoietic anemia.
    Adams CD; Kessler JF
    Am J Hematol; 1991 Oct; 38(2):120-3. PubMed ID: 1951301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroblast multinuclearity in bone marrow and spleen. Congenital dyserythropoietic anemia-like abnormalities without functional evidence of dyserythropoiesis.
    Lillicrap DP; Corbett WE; Giles AR; Ginsburg AD
    Arch Pathol Lab Med; 1987 Jun; 111(6):536-9. PubMed ID: 3579510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood features of iron overload in post-splenectomy, type I congenital dyserythropoietic anemia.
    Dexter D; Layton DM; Kiritkumar K; Bain BJ
    Am J Hematol; 2022 Feb; 97(2):237-238. PubMed ID: 34416046
    [No Abstract]   [Full Text] [Related]  

  • 7. The newt as a model for studying dyserythropoiesis.
    Garavini C
    Naturwissenschaften; 1981 Aug; 68(8):432-3. PubMed ID: 7279002
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anemia caused by congenital dyserythropoiesis: type II (Hempas). Value of splenectomy].
    Sondag D; Weill JP; Oberling F
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2419. PubMed ID: 7111012
    [No Abstract]   [Full Text] [Related]  

  • 9. [Favorable effect of splenectomy on anemia in 3 siblings with type II congenital dyserythropoietic anemia (HEMPAS). (Ultrastructural changes in erythrocytes after splenectomy)].
    Chrobák L; Spacek J
    Vnitr Lek; 1997 Oct; 43(10):635-8. PubMed ID: 9601875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital dyserythropoiesis and progressive alopecia in Polled Hereford calves: hematologic, biochemical, bone marrow cytologic, electrophoretic, and flow cytometric findings.
    Steffen DJ; Elliott GS; Leipold HW; Smith JE
    J Vet Diagn Invest; 1992 Jan; 4(1):31-7. PubMed ID: 1348189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of iron overload with phlebotomies in two siblings with congenital dyserythropoietic anemia--type II (CDA-II).
    Chrobák L
    Acta Medica (Hradec Kralove); 2006; 49(3):193-5. PubMed ID: 17117609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous studies with Fe59 and Cr51 in congenital haemolytic anaemias.
    MALAMOS B; BELCHER EH; GYFTAKI E; BINOPOULOS D
    Nucl Med (Stuttg); 1961 Sep; 2():1-20. PubMed ID: 14468792
    [No Abstract]   [Full Text] [Related]  

  • 13. Red cell survival and iron kinetics in kala-azar.
    Musumeci S; Romeo M; D'Agata A
    J Trop Med Hyg; 1974 May; 77(5):106-10. PubMed ID: 4835324
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies with '59 iron and 51 chromium in various anaemias in South Africa.
    METZ J; KRAWITZ S; HART D
    East Afr Med J; 1962 May; 39():268-74. PubMed ID: 14473044
    [No Abstract]   [Full Text] [Related]  

  • 15. A simple in vitro method for the assessment of ineffective erythropoiesis.
    Samson D; Tikerpae J; Crowne H
    Blood; 1981 Oct; 58(4):782-7. PubMed ID: 7272508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An example of anti-Yta demonstrating a change in its clinical significance.
    AuBuchon JP; Brightman A; Anderson HJ; Kim B
    Vox Sang; 1988; 55(3):171-5. PubMed ID: 3238951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyserythropoiesis and dyserythropoietic anemias.
    Lewis SM; Verwilghen RI
    Prog Hematol; 1973; 8():99-129. PubMed ID: 4788378
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the understanding of the congenital dyserythropoietic anaemias.
    Wickramasinghe SN; Wood WG
    Br J Haematol; 2005 Nov; 131(4):431-46. PubMed ID: 16281933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological studies of erythrocytes in congenital dyserythropoietic anemia type II].
    Koehler M; Schmidt-Riese L; Brandeis WE
    Acta Haematol Pol; 1990; 21(2):144-52. PubMed ID: 2131714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isotopic studies as a guide for splenectomy in myeloid metaplasia with myelofibrosis (author's transl)].
    Celada A; Laso FJ; Rudolf H; Herreros V; Donath A
    Sangre (Barc); 1977; 22(3):294-303. PubMed ID: 867208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.